Page last updated: 2024-08-17

galactose and Infections, Orthomyxoviridae

galactose has been researched along with Infections, Orthomyxoviridae in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Gonzalez-Juarbe, N; Lin, YH; Mares, CA; Penix, T; Platt, MP; Rosch, JW; Vashee, I; Wiscovitch-Russo, R; Yu, Y1
Chan, MCW; Chan, VSF; Lau, SPN; Peiris, M; Poh, CM; Poon, LLM; Yan, LM1
Goldie, RG; Henry, PJ; Lan, RS; Stewart, GA1

Other Studies

3 other study(ies) available for galactose and Infections, Orthomyxoviridae

ArticleYear
A multiomics analysis of direct interkingdom dynamics between influenza A virus and Streptococcus pneumoniae uncovers host-independent changes to bacterial virulence fitness.
    PLoS pathogens, 2022, Volume: 18, Issue:12

    Topics: Galactose; Humans; Influenza A virus; Influenza, Human; Multiomics; Orthomyxoviridae Infections; Proteomics; Streptococcus pneumoniae; Virulence

2022
Heterosubtypic Protection Induced by a Live Attenuated Influenza Virus Vaccine Expressing Galactose-α-1,3-Galactose Epitopes in Infected Cells.
    mBio, 2020, 03-03, Volume: 11, Issue:2

    Topics: Animals; Cross Reactions; Epitopes; Galactose; Humans; Immunogenicity, Vaccine; Influenza A virus; Influenza Vaccines; Killer Cells, Natural; Macrophages; Mice; Mice, Inbred BALB C; Mice, Knockout; Orthomyxoviridae Infections; Vaccines, Attenuated

2020
Altered expression and in vivo lung function of protease-activated receptors during influenza A virus infection in mice.
    American journal of physiology. Lung cellular and molecular physiology, 2004, Volume: 286, Issue:2

    Topics: Airway Resistance; Animals; Bronchoconstrictor Agents; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Galactose; Gene Expression; Indomethacin; Influenza A virus; Isoenzymes; Male; Methacholine Chloride; Mice; Mice, Inbred CBA; Orthomyxoviridae Infections; Peptides; Prostaglandin-Endoperoxide Synthases; Receptor, PAR-1; Receptor, PAR-2; Receptors, Proteinase-Activated; Respiratory Mucosa; Trachea

2004